Arco Lab Profile
Key Indicators
- Authorised Capital ₹ 4.50 M
as on 22-06-2024
- Paid Up Capital ₹ 3.53 M
as on 22-06-2024
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 50.00 Cr
as on 22-06-2024
- Revenue 31.05%
(FY 2023)
- Profit 262.25%
(FY 2023)
- Ebitda 130.67%
(FY 2023)
- Net Worth 825.31%
(FY 2023)
- Total Assets 278.41%
(FY 2023)
About Arco Lab
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.50 M and a paid-up capital of Rs 3.53 M.
The company currently has active open charges totaling ₹50.00 Cr.
Shashidhar Lingaraj, Vinod Bhaskaran, and Stuti Sharma serve as directors at the Company.
- CIN/LLPIN
U74999KA2018PTC115573
- Company No.
115573
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Aug 2018
- Date of AGM
28 Jul 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Arco Lab?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shashidhar Lingaraj  | Whole-Time Director | 01-Dec-2018 | Current |
| Vinod Bhaskaran | Whole-Time Director | 14-May-2021 | Current |
| Stuti Sharma | Whole-Time Director | 25-Jul-2023 | Current |
Financial Performance of Arco Lab.
Arco Lab Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 31.05% increase. The company also saw a substantial improvement in profitability, with a 262.25% increase in profit. The company's net worth Soared by an impressive increase of 825.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arco Lab?
In 2023, Arco Lab had a promoter holding of 100.00%. The company had 1 Subsidiary and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Strides Pharma Services Private LimitedActive 2 years 5 monthsShashidhar Lingaraj and Vinod Bhaskaran are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 Jun 2023 | ₹50.00 Cr | Open |
How Many Employees Work at Arco Lab?
Arco Lab has a workforce of 350 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arco Lab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arco Lab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
